摘要:
A method and system for automatically configuring a plurality of wireless peripheral devices within a network environment. The method includes identifying a plurality of wireless peripheral devices, including one existing networked wireless device. The existing networked wireless device is configured to function as a master device. The master device identifies one of the remaining wireless peripheral devices that has yet to be configured. The master device replicates itself by wirelessly transmitting the configuration data to the identified wireless peripheral device. The configuration data enables the identified peripheral wireless device to assume network operation and to assume functionality of the master device so as to be capable of automatically causing the configuration of additional peripheral devices.
摘要:
A method and system for automatically configuring a plurality of wireless peripheral devices within a network environment. The method includes identifying a plurality of wireless peripheral devices, including one existing networked wireless device. The existing networked wireless device is configured to function as a master device. The master device identifies one of the remaining wireless peripheral devices that has yet to be configured. The master device replicates itself by wirelessly transmitting the configuration data to the identified wireless peripheral device. The configuration data enables the identified peripheral wireless device to assume network operation and to assume functionality of the master device so as to be capable of automatically causing the configuration of additional peripheral devices.
摘要:
This invention relates to compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in the inhibition of receptor signaling, for example, the inhibition of VEGF receptor signaling. The invention also provides compounds, compositions and methods for treating cell proliferative diseases and conditions and opthalmological diseases, disorders and conditions.
摘要:
A configuration tool and method of updating a pointer entry in a Java archive (JAR) file pointing to a peripheral configuration file comprises generally continuously listening for an event signifying deployment of a peripheral configuration file and in response to the event, automatically updating the pointer entry in the JAR file that points to the deployed peripheral configuration file.
摘要:
This invention relates to compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in the inhibition of receptor signaling, for example, the inhibition of VEGF receptor signaling. The invention also provides compounds, compositions and methods for treating cell proliferative diseases and conditions and ophthalmic diseases, disorders and conditions.
摘要:
This invention provides novel β-lactamase inhibitors of the aryl- and heteroaryl-sulfonamidomethylphosphonate monoester class having nitrogen-based cations or quarternary ammomium groups. The compounds inhibit three classes of β-lactamases and synergize the antibacterial effects of β-lactam antibiotics (e.g., imipenem and ceftazimdime) against those micro-organisms normally resistant to the β-lactam antibiotics as a result of the presence of the β-lactamases.
摘要:
This invention relates to compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in the inhibition of receptor signaling, for example, the inhibition of VEGF receptor signaling and HGF receptor signaling. More particularly, the invention relates to compounds, compositions and methods for the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.
摘要:
This invention relates to processes and intermediates for manufacturing fused heterocyclic-type kinase inhibitor compounds, such as thienopyridine-based compounds, and to processes and intermediates for preparing intermediates that are useful in the manufacture of fused heterocyclic-type kinase inhibitor compounds, such as thienopyridine-based compounds, particularly at an industrial level.
摘要:
This invention relates to compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in the inhibition of receptor signaling, for example, the inhibition of VEGF receptor signaling and HGF receptor signaling. More particularly, the invention relates to compounds, compositions and methods for the inhibition of VEGF receptor signaling and HGF receptor signaling. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.
摘要:
This invention relates to processes and intermediates for manufacturing fused heterocyclic-type kinase inhibitor compounds, such as thienopyridine-based compounds, and to processes and intermediates for preparing intermediates that are useful in the manufacture of fused heterocyclic-type kinase inhibitor compounds, such as thienopyridine-based compounds, particularly at an industrial level.